跳至主要内容
临床试验/JPRN-UMIN000043703
JPRN-UMIN000043703已完成未知

A Prospective Observational Study in Nivolumab Therapy for Advanced or Recurrent Esophageal Squamous Cell Carcinoma after Cancer Chemotherapy - ANTARES study

Keio University0 个研究点目标入组 200 人开始时间: 2021年3月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Active multiple cancer (synchronous multiple cancer or metachronous multiple cancer where patient has been disease-free for less than 3 years) 2) Prior therapy with anti-PD-1 antibodies (e.g., nivolumab, pembrolizumab), anti-PD-L1 antibodies (e.g., Avelumab, Atezolizumab), anti-CTLA-4 antibodies (e.g., Ipilimumab), or other drugs for T-cell regulation. 3) Receipt of systemic corticosteroids (except for temporary use for testing or prophylactic administration) in excess of 10 mg/day of prednisolone equivalent or or immunosuppressive agents within 14 days prior to enrollment. 4) Patients who have received antibiotics within 14 days prior to registration (Topical medications are acceptable). 5) Patients with the following complications or history of complications a) Complications or history of interstitial lung disease b) Obvious interstitial shadows on chest imaging c) Inflammatory changes due to active radiation pneumonia or infectious pneumonia on chest imaging. d) History of autoimmune disease, or chronic or recurrent autoimmune disease e) History of organ transplantation (including hematopoietic stem cell transplantation). f) Active or history of tuberculosis. 6) Patients deemed unsuitable as study subjects by an investigator for any other reason

研究者

相似试验

招募中
Unknown
Prospective observational study examining the impact of sarcopenia in the treatment of advanced stage lung cancer.lung cancer
JPRN-UMIN000050295iigata university150
招募中
不适用
Clinical observational study for evaluation of the therapy outcome and the dependency of the outcome on parameters as reconstruction type and/or vitamin D level in OMS tumor patients in need of intra-oral tumor resection and reconstructioC01C02C03C04C05C06C44C40C41C07C08C09C10C11C12C13C14Malignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of gumMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthOther malignant neoplasms of skinMalignant neoplasm of bone and articular cartilage of limbsMalignant neoplasm of bone and articular cartilage of other and unspecified sitesMalignant neoplasm of parotid glandMalignant neoplasm of other and unspecified major salivary glandsMalignant neoplasm of tonsilMalignant neoplasm of oropharynxMalignant neoplasm of nasopharynxMalignant neoplasm of piriform sinusMalignant neoplasm of hypopharynxMalignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
DRKS00025841niversitätsklinikum derGoethe-Universität Frankfurt am MainKlinik für Mund-, Kiefer- und Plastische Gesichtschirurgie100
招募中
不适用
A prospective observational study for patients with community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia in a Japanese University Hospitalcommunity-acquired (CAP), health-care-associated (HCAP), hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)
JPRN-UMIN000007090Department of Respiratory Medicine, Nagoya University Graduate School of Medicine1,420
进行中(未招募)
不适用
An observational study in patients who received nivolumab preoperatively for stage 1 non-small cell lung cancer considered as high-risk of relapsenon small cell lung cancer
JPRN-jRCT1060190007Okada Morihito50
招募中
Unknown
An observational, prospective study to assess the efficacy and safety of Adalloce in patients with Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS)Diseases of the musculoskeletal system and connective tissue
KCT0009141Yuhan1,000